Cel Sci Corporation (CVM)

[lightrock]

Taking a look around the block, so to speak, every single similar company I see took a huge hit right at the same time as we did.

Something noteworthy must have failed and or the pharma over charge congressional noises, etc., or our cheese has moved and we are missing out on a company with a winner going.

So as always, I see Multikine is not worthless, that's what I'm here for.

The founders are knowledgeable on it more than anyone except the CROs, and the CROs are knowledgeable on it, and it is a very large study, the test group of patients in knowledgeable on it. (i.e., how can there be no leaks)

Even at the valuation you propose, a successful phase III should yield a company with an MC into the mid 300M, no ? ( if not more )

Therefore it has potential to be very cheap still, to the right eyes.